Freestone Grove Partners’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7M Sell
298,653
-1,014,356
-77% -$57.9M 0.1% 234
2026
Q1
$77.9M Sell
1,313,009
-1,761,916
-57% -$85M 0.55% 34
2025
Q4
$121M Buy
3,074,925
+1,365,535
+80% +$52.9M 0.87% 6
2025
Q3
$69M Sell
1,709,390
-542,391
-24% -$22.1M 0.52% 46
2025
Q2
$85.7M Buy
2,251,781
+797,032
+55% +$29.3M 0.65% 31
2025
Q1
$62.3M Buy
1,454,749
+337,633
+30% +$14.4M 0.64% 35
2024
Q4
$45.2M Buy
+1,117,116
New +$46.5M 0.55% 61

Other funds holding OVV

Freestone Grove Partners's OVV Position: Q2 2026 in Review

Freestone Grove Partners reduced its Ovintiv (OVV) stake by 77% in Q2 2026, selling an estimated $57.9M and leaving 298,653 shares worth $15.7M. The position accounts for 0.1% of the portfolio, ranked #234.

Freestone Grove Partners first reported a position in OVV in Q4 2024 and has held it in 7 quarters since. The position peaked at $121M in Q4 2025. 593 funds tracked by Wall St. Rank hold OVV as of Q2 2026.

  • Freestone Grove Partners held 298,653 shares of Ovintiv worth $15.7M as of Q2 2026.
  • Freestone Grove Partners sold 1,014,356 Ovintiv shares in Q2 2026, an estimated $57.9M.
  • Ovintiv made up 0.1% of Freestone Grove Partners's portfolio in Q2 2026, its #234 holding.
  • Freestone Grove Partners first reported a position in Ovintiv in Q4 2024 and has held it in 7 quarters since.
  • Freestone Grove Partners's Ovintiv position peaked at $121M in Q4 2025.
  • 593 funds tracked by Wall St. Rank held Ovintiv as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.